Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2 320
17 000
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Sejahteraraya Anugrahjaya Tbk PT
Cash & Cash Equivalents
Sejahteraraya Anugrahjaya Tbk PT
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Sejahteraraya Anugrahjaya Tbk PT
IDX:SRAJ
|
Cash & Cash Equivalents
Rp2T
|
CAGR 3-Years
118%
|
CAGR 5-Years
49%
|
CAGR 10-Years
22%
|
|
|
Siloam International Hospitals Tbk PT
IDX:SILO
|
Cash & Cash Equivalents
Rp853B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
18%
|
|
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
Cash & Cash Equivalents
Rp956.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Metro Healthcare Indonesia Tbk PT
IDX:CARE
|
Cash & Cash Equivalents
Rp449.1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
130%
|
CAGR 10-Years
N/A
|
|
|
Mitra Keluarga Karyasehat Tbk PT
IDX:MIKA
|
Cash & Cash Equivalents
Rp1.9T
|
CAGR 3-Years
335%
|
CAGR 5-Years
131%
|
CAGR 10-Years
46%
|
|
|
F
|
Famon Awal Bros Sedaya Tbk PT
IDX:PRAY
|
Cash & Cash Equivalents
Rp894.8B
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sejahteraraya Anugrahjaya Tbk PT
Glance View
Sejahteraraya Anugrahjaya Tbk PT, widely recognized as a pivotal player in Indonesia’s healthcare sector, stands out for its commitment to providing high-quality medical services through its premier brand, Mayapada Hospital. The company operates an expanding network of hospitals strategically positioned to serve Indonesia's bustling metropolitan areas, catering to a diverse demographic in need of trusted and reliable healthcare. Each facility under Sejahteraraya Anugrahjaya is equipped with advanced medical technology and accredited healthcare professionals, which not only attract domestic patients but also garner interest from international clientele seeking specialized treatment. This emphasis on quality and accessibility forms the backbone of its business model, while diversifying services ensures both steady revenue flow and resilience against economic fluctuations. By focusing on a broad range of healthcare services—from general consultations and diagnostics to specialized medical treatments and emergency care—Sejahteraraya Anugrahjaya Tbk PT secures various revenue streams. The institution capitalizes on Indonesia's growing demand for healthcare services driven by its burgeoning middle class and increasing health consciousness among the population. Insurance partnerships and direct patient payments constitute primary income channels, further enhanced by healthcare innovations and expansions. Through continuous investments in building state-of-the-art facilities and fostering strategic alliances, the company adeptly navigates the competitive healthcare landscape, ensuring sustainable growth and setting a benchmark for medical excellence in the region.
See Also
What is Sejahteraraya Anugrahjaya Tbk PT's Cash & Cash Equivalents?
Cash & Cash Equivalents
2T
IDR
Based on the financial report for Sep 30, 2025, Sejahteraraya Anugrahjaya Tbk PT's Cash & Cash Equivalents amounts to 2T IDR.
What is Sejahteraraya Anugrahjaya Tbk PT's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
22%
Over the last year, the Cash & Cash Equivalents growth was 562%. The average annual Cash & Cash Equivalents growth rates for Sejahteraraya Anugrahjaya Tbk PT have been 118% over the past three years , 49% over the past five years , and 22% over the past ten years .